145 related articles for article (PubMed ID: 34446316)
1. Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation.
Tost J; Llorens P; Cotter G; Davison B; Jacob J; Gil V; Herrero P; Martín-Sánchez FJ; Donea R; Rodríguez B; Lucas-Imbernon FJ; Andueza JA; Mecina AB; Torres-Gárate R; Piñera P; Alquézar-Arbé A; Espinosa B; Mebazaa A; Chioncel O; Miró Ò;
Eur J Intern Med; 2021 Dec; 94():73-84. PubMed ID: 34446316
[TBL] [Abstract][Full Text] [Related]
2. Short-term outcomes of heart failure patients with reduced and preserved ejection fraction after acute decompensation according to the final destination after emergency department care.
Miró Ò; Gil VÍ; Martín-Sánchez FJ; Jacob J; Herrero P; Alquézar A; Llauger L; Aguiló S; Martínez G; Ríos J; Domínguez-Rodríguez A; Harjola VP; Müller C; Parissis J; Peacock WF; Llorens P;
Clin Res Cardiol; 2018 Aug; 107(8):698-710. PubMed ID: 29594372
[TBL] [Abstract][Full Text] [Related]
3. Outcomes among acute heart failure emergency department patients by preserved vs. reduced ejection fraction.
Sax DR; Rana JS; Mark DG; Huang J; Collins SP; Liu D; Storrow AB; Reed ME;
ESC Heart Fail; 2021 Aug; 8(4):2889-2898. PubMed ID: 33978311
[TBL] [Abstract][Full Text] [Related]
4. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M; Friberg L
JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
[TBL] [Abstract][Full Text] [Related]
5. Starting Neurohormonal Antagonists in Patients With Acute Heart Failure With Mid-Range and Preserved Ejection Fraction.
Seko Y; Kato T; Morimoto T; Yaku H; Inuzuka Y; Tamaki Y; Ozasa N; Shiba M; Yamamoto E; Yoshikawa Y; Yamashita Y; Kitai T; Taniguchi R; Iguchi M; Nagao K; Kawai T; Komasa A; Nishikawa R; Kawase Y; Morinaga T; Toyofuku M; Furukawa Y; Ando K; Kadota K; Sato Y; Kuwahara K; Kimura T;
Circ J; 2022 Sep; 86(10):1547-1558. PubMed ID: 35153273
[TBL] [Abstract][Full Text] [Related]
6. Effect of Prescribing Patterns of Renin-Angiotensin System Blockers and Beta-Blockers on Prognosis of Heart Failure.
Kim HJ; Jo SH; Lee MH; Seo WW; Choi JO; Ryu KH
Adv Ther; 2020 Sep; 37(9):3839-3849. PubMed ID: 32676928
[TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of Short-Term Outcomes of Patients With Heart Failure With a Mid-Range Ejection Fraction After Acute Decompensation.
Miró Ò; Javaloyes P; Gil V; Martín-Sánchez FJ; Jacob J; Herrero P; Marco-Hernández J; Ríos J; Harjola VP; Torres-Gárate R; Alonso MI; Piñera P; Mecina AB; Escoda R; Müller C; Parissis J; Llorens P;
Am J Cardiol; 2019 Jan; 123(1):84-92. PubMed ID: 30360888
[TBL] [Abstract][Full Text] [Related]
8. Prognostic association of medication trajectories with 3-year mortality in heart failure and preserved ejection fraction: findings from the EPICAL2 cohort study.
Bitar S; Thilly N; Agrinier N
Eur J Clin Pharmacol; 2021 Oct; 77(10):1569-1581. PubMed ID: 33970296
[TBL] [Abstract][Full Text] [Related]
9. Analysis of How Emergency Physicians' Decisions to Hospitalize or Discharge Patients With Acute Heart Failure Match the Clinical Risk Categories of the MEESSI-AHF Scale.
Miró Ò; Rossello X; Gil V; Martín-Sánchez FJ; Llorens P; Herrero-Puente P; Jacob J; Piñera P; Mojarro EM; Lucas-Imbernón FJ; Llauger L; Agüera C; López-Díez MP; Valero A; Bueno H; Pocock SJ;
Ann Emerg Med; 2019 Aug; 74(2):204-215. PubMed ID: 31147102
[TBL] [Abstract][Full Text] [Related]
10. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M
JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
[TBL] [Abstract][Full Text] [Related]
11. Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.
Ahn MS; Yoo BS; Son JW; Yu MH; Kang DR; Lee HY; Jeon ES; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY
J Korean Med Sci; 2020 Aug; 35(33):e278. PubMed ID: 32830467
[TBL] [Abstract][Full Text] [Related]
12. Association between anemia and outcome in patients hospitalized for acute heart failure syndromes: findings from Beijing Acute Heart Failure Registry (Beijing AHF Registry).
Ye SD; Wang SJ; Wang GG; Li L; Huang ZW; Qin J; Li CS; Yu XZ; Shen H; Yang LP; Fu Y; Zheng YA; Zhao B; Yu DM; Qin FJ; Zhou DG; Li Y; Liu FJ
Intern Emerg Med; 2021 Jan; 16(1):183-192. PubMed ID: 32356137
[TBL] [Abstract][Full Text] [Related]
13. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
14. BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure.
Miró Ò; Müller C; Martín-Sánchez FJ; Bueno H; Mebazaa A; Herrero P; Jacob J; Gil V; Escoda R; Llorens P;
Clin Res Cardiol; 2016 Dec; 105(12):1021-1029. PubMed ID: 27379611
[TBL] [Abstract][Full Text] [Related]
15. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
[TBL] [Abstract][Full Text] [Related]
16. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
[TBL] [Abstract][Full Text] [Related]
17. Patients with acute heart failure discharged from the emergency department and classified as low risk by the MEESSI score (multiple risk estimate based on the Spanish emergency department scale): prevalence of adverse events and predictability.
Miró Ò; Gil V; Rosselló X; Martín-Sánchez FJ; Llorens P; Jacob J; Herrero P; Herrera Mateo S; Richard F; Escoda R; Fuentes M; Martín Mojarro E; Llauger L; Bueno H; Pocock S
Emergencias; 2019 Feb; 31(1):5-14. PubMed ID: 30656867
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF.
Jering KS; Zannad F; Claggett B; Mc Causland FR; Ferreira JP; Desai A; Barkoudah E; McMurray JJV; Pfeffer MA; Solomon SD
JACC Heart Fail; 2021 Jan; 9(1):13-24. PubMed ID: 33189633
[TBL] [Abstract][Full Text] [Related]
19. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry.
Yoshikawa Y; Tamaki Y; Morimoto T; Yaku H; Yamamoto E; Inuzuka Y; Ozasa N; Kitai T; Nagao K; Sato Y; Kondo H; Tamura T; Nakagawa Y; Kuwahara K; Kato T; Kimura T
PLoS One; 2020; 15(9):e0239100. PubMed ID: 32925953
[TBL] [Abstract][Full Text] [Related]
20. Mortality after an episode of acute heart failure in a cohort of patients with intermediate ventricular function: Global analysis and relationship with admission department.
Miró Ò; Javaloyes P; Gil V; Jacob J; Herrero-Puente P; Martín-Sánchez FJ; Salvo E; Alonso H; Juan Gómez MÁ; Parissis J; Llorens P;
Med Clin (Barc); 2018 Sep; 151(6):223-230. PubMed ID: 29279134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
